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Objectives: We undertook this study to calculate the cost per life-year gained in the first round of a screening program for
abdominal aortic aneurysm (AAA) and to estimate the costs in a subsequent round.
Methods: This was an intervention study, with follow-up for ruptured aneurysms. Men older than 50 years were screened
for asymptomatic AAA. Outcome measures included cost per life-year saved and number of men needed to be screened to
save one life.
Results: The incidence of ruptured AAA was 2.6 per 10,000 person- years in the screening group and 7.1 per 10,000
person-years in the control group. Screening is estimated to have prevented 10.8 ruptured AAA and 8 deaths per year,
gaining 51 life-years per year for the study population, and to have reduced the incidence of ruptured AAA by 64% (95%
CI, 42%-77%). Each life-year gained during the first screening round cost $1107. To save one life, 1000 men need to be
screened and 5 elective operations performed. We predict that a second round of screening can be cost neutral.
Conclusions: The cost-effectiveness of screening for AAA compares favorably with screening programs for other disorders
in adults. (J Vasc Surg 2003;38:72-7.)
Ruptured abdominal aortic aneurysm (AAA) is com-
mon in elderly men. In 2000, 4028 deaths in England and
Wales were attributed to ruptured AAA, accounting for
1.4% of all deaths in men older than 65 years.1 When an
AAA ruptures, true mortality is more than 80%.2,3 Inas-
much as screening of the abdominal aorta with ultrasound
is quick, inexpensive, and accurate,4,5 and elective surgery
has acceptably low mortality, a national screening program
has been advocated.6 Published attempts to estimate the
cost-benefit ratio of screening for AAA have relied on
assumptions derived from the literature rather than on real
data. Thus it is not surprising that studies have reached
contradictory conclusions, with some in favor of screen-
ing6-8 and others claiming that it cannot be justified.9,10
Screening for AAA can be justified if two main criteria are
met: it must be effective in reducing the death rate from
ruptured AAA, and it must be cost effective, ie, provide
good value for the money compared with other health
improvement programs.
A screening program for AAA was started in 1991. Our
goal was to calculate the cost per life-year gained in the first
round of the program and to predict future cost if screening
is continued after completion of the first screening round.
METHODS
Study population. The study population comprised
the entire male population older than 50 years registered
with a general practitioner in Huntingdon District. Screen-
ing for AAA began in November 1991; however, we chose
to conduct our study from January 1, 1991, to December
31, 2000. In June 1998 a second round of screening was
started, and all men older than 55 years were invited to
undergo screening for a second time, on average after 5.5
years.
The purpose of our study was to compare the incidence
and mortality of ruptured AAA in a control group with that
in a screening group to determine whether life-years could
be saved with screening. The study was approved by the
Cambridge and Huntingdon Local Ethics Committee.
Methods of recruitment and screening are described
elsewhere.11 In brief, men older than 50 years in the
District were identified through general practitioners, and
groups were successively invited for screening. At the out-
set, we predicted that the entire study population would
eventually be invited over 7 years, ie, the first round of
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screening. In practice, approximately 90% coverage was
achieved after 9 years, because the male population older
than 50 years increased by 35% during that time.1
Screening was organized in one general practice at a
time, and subjects were invited for screening by their gen-
eral practitioner; no subject could invite himself. All sub-
jects were entered in the control group and were transferred
to the screening group when they had been invited for
screening (Figure). Membership in the groups thus de-
pended on “intention to screen” rather than on whether
screening had been performed.
Tracing ruptured AAA. A thorough attempt was
made to trace all ruptured AAA occurring in the District
during the study period, whether or not the patient reached
the hospital. A particular advantage in our study population
is that Hinchingbrooke Hospital is the only general hospi-
tal in the District, and all patients with ruptured AAA would
have been taken there. Since 1990, all operations per-
formed in the hospital have been logged in the hospital
Contracts and Medical Admissions Information System.
Since 1988, all coroner postmortem examinations per-
formed because of sudden unexpected death in the com-
munity were done at Hinchingbrooke Hospital. In Hunt-
ingdon, all sudden death cases, occurring in persons not
seen by a general practitioner in the 2 weeks before death,
are referred to the coroner and undergo postmortem ex-
amination. A combination of methods was used to trace all
ruptured AAA occurring in the district between January 1,
1991, and December 31, 2000. First, patients admitted to
the hospital were identified by means of the hospital com-
puter system, intensive care unit (ICU) admission records,
and operating room registers. Second, accident and emer-
gency department records were examined to find patients
with a ruptured AAA who had died in the department or
who were transferred to another hospital because of lack of
beds. Last, all postmortem reports on community patients
during the study period were scrutinized to find any sudden
deaths due to ruptured AAA outside of the hospital.
Comparison of screening and control groups. A
stepped wedge design was used to compare incidence rates
in the screened cohort and control group. In this design,
each member of the screening group acts as his own control
for the period before being invited for screening.12,13 Over
the study period, the entire study population was scruti-
nized for mortality from ruptured AAA, and individual
patients were reconciled with membership in the screening
group or the control group. Patients with aneurysm rup-
ture were allocated to either the “invited” group or the
“not invited” group (control group) on the basis of inten-
tion to screen. A patient was allocated to the invited group
if rupture occurred at a date later than the date of the first
screening appointment, and to the not invited group if
rupture occurred before the patient had been invited for
screening. The period of observation in both groups was
measured in person-years. Follow-up in the control group
was calculated by subtracting total follow-up in the screen-
ing group from that of the entire study population.
Calculation of cost. Cost for emergency or elective
AAA repair was calculated separately. Average duration of
hospital stay and of ICU stay was estimated by examining
hospital notes and computer records for all emergency AAA
repairs performed in the hospital between 1986 and 2000.
Cost calculation for elective AAA repair was based on data
from actual repair procedures during the study period. The
number of blood products transfused in each AAA case
between 1990 and 2000 was used to determine the average
requirement. To establish accurate average ICU cost, all
expenses for 46 elective repair procedures and 7 emergency
repair operations (ruptured AAA) performed over 3 years in
the middle of the study period were examined in detail. A
tally of all costs incurred in the ICU was made for each case,
and the average was calculated to arrive at a representative
daily ICU cost for aneurysm surgery. Cost for the operating
room per hour and hospital stay per day were obtained from
the hospital finance department. Average costs during
1995 and 1996 were chosen as a representative estimate of
average costs incurred over the study period. The cost for a
computed tomography (CT) scan in 1995 was added to the
cost of elective aneurysm repair, because all patients who
received elective AAA repair and no patients who received
emergency AAA repair underwent preoperative CT. All
expenses incurred in the screening program during 1995
were used to estimate the average annual cost of the screen-
ing program.
Calculation of benefit. In calculating the number of
ruptured AAA prevented with screening, estimated inci-
dence for the control group was assumed approximate to
the background incidence in the absence of screening. This
corresponded well with findings of a previous local retro-
spective study.2 Life tables from the Office of National
Statistics for England and Wales were used to calculate
potential average life expectancy from the age of rupture.
Fig 1. Illustration of stepped wedge design, and calculation of
person-years follow-up of invited and not invited populations. Y
axis shows cumulative percentage of population invited for screen-
ing. First screening round ended in June 1998. Increase in male
population older than 50 years accounts for decline in percentage
invited.
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Together these data were used to calculate average life-
years gained as a result of preventing ruptured aneurysm
with screening. From this was deducted the average life-
years lost as a result of perioperative death after elective
repair of aneurysm detected at screening.
RESULTS
Benefits. In total, 93 ruptured AAA were found in
men older than 50 years during the study period, 24 in the
group invited for screening and 69 in the control group.
Forty-three patients (46%) underwent emergency repair,
and 22 men (24%) survived a ruptured AAA. Thus 71
deaths occurred as a result of ruptured AAA during the
study period, 17 in the screening group and 54 in the
control group. The overall (community and hospital) mor-
tality of ruptured AAA in men over the study period was
76%.
The response rate to the screening invitation was 74%.
The incidence of rupture in the screening group was 2.6 per
10,000 person-years (95% confidence interval [CI], 1.7-
3.8), compared with 7.1 per 10,000 person-years in the
control group (95% CI, 5.6-8.9) (Table I). This corre-
sponds to a 64% reduction in incidence in the screening
group (95% CI, 42%-77%). On this basis, 4.5 ruptured
AAA per 10,000 person-years are likely to have been pre-
vented with screening. There are approximately 23,300
men older than 50 years in the district. Thus the number of
ruptured AAA prevented each year with screening can be
estimated as 2.3 4.5 10.4 ruptured AAA. Overall local
mortality of ruptured AAA was 76%; therefore the potential
number of lives saved per year with screening was 10.4 
76% 8 lives. Average age at rupture in our patients was 75
years, and at that age life expectancy for men is 8.6 years.
We estimated a lower relative survival of 80% after aneu-
rysm surgery compared with that in an age-matched popu-
lation, on the basis of findings of three studies14-16 that
examined relative survival after aneurysm repair. Therefore,
for each year of screening, 8 lives with a life expectancy of
6.9 years (80% of 8.6) were saved. Thus an estimated 54
life-years were gained per year of screening in a population
of 23,000 men at risk.
During the study, 149 elective repairs of AAA were
performed; 98 of these AAA were detected with screening.
Thus, on average 10 elective repairs per year are performed
as a result of screening. Of the 149 patients who underwent
elective repair, 6 died, for an elective repair mortality rate of
4% (95% CI, 1.6%-7.7%). Average age of patients who died
with elective aneurysm repair was 80 years; average life
expectancy at 80 is 6.4 years. However, because this esti-
mate was based on only 4 deaths, we used a similar average
age at death with elective repair as for death with emer-
gency repair. Average life expectancy at 75 is 8.6 years.
Using our in-hospital elective repair mortality rate of 4%,
we would expect a loss of life-years of (10  4%)  (8.6 
80%)  2.8 years in each year for the entire population at
risk. The net annual life years gained each year with screen-
ing in our population can be calculated as 54 2.8 51.2
years.
Cost. Total cost of the screening program in 1995 was
$23,230. Data regarding hospital stay, ICU stay, and other
costs for emergency and elective repair of AAA are shown in
Table II. Average cost for 1 day in the ICU associated with
emergency aneurysm repair was $1635, compared with
$1615 for elective repair. We have taken $1615 as the
average cost of 1 day in the ICU for both elective and
emergency repair, because individual ICU cost calculations
were made on the basis of 46 elective repairs and only 7
emergency repairs. Estimated cost of emergency and elec-
tive AAA repair used in cost-effectiveness calculations are
shown in Table III. We used mean stay in the ICU as an
estimate for the average, although it is more sensitive for
outliers. Estimated operating room cost for AAA repair,
including personnel, operating room time, and all consum-
able goods, was similar for elective and emergency repair, at
$1611. Average cost of 1 day in a surgical ward in 1995 and
1996 was calculated by the hospital finance department at
$144. The hospital ward cost for AAA was estimated as
mean hospital stay times cost per day.
Cost-effectiveness analysis. Annual cost for screen-
ing and treating detected cases included cost of the screen-
ing program (Table IV) and cost of additional elective AAA
repair procedures resulting from it, less savings for emer-
gency repairs. Sixty percent of patients with ruptured AAA
in the community die without an operation.2 Thus hospital
savings for emergency repairs is calculated as, 40% of the
number of ruptured AAA prevented per year times average
cost of emergency repair. Cost-effectiveness analysis for the
first 5 years of screening is shown in Table V. If 51 life-years
are gained per year, at an annual cost of $56,845, the cost
per life-year saved is $1107.
Cost-effectiveness calculation for a first round of
screening gives higher costs, because of the extra workload
of operating on prevalent AAA (Table VI). In further
screening rounds, the number of large aneurysms requiring
surgery would be lower and the costs correspondingly
reduced. For future rounds, the cost of elective aneurysm
repair would include only treatment of small aneurysms
that have expanded, large AAA detected in patients moving
into the District and those in men reaching the eligible age
for screening, plus a small number in men who initially
refused screening.
Table I. Incidence of ruptured AAA over 5 years
Group
No. of
ruptured
AAA
Follow-up
(person-
years) Rate* 95% CI
Entire male population
older than 50 years
93 189 738 4.9 4.0 to 6.0
Invited for screening 24 92 939 2.6 1.7 to 3.8
Not invited 69 96 799 7.1 5.6 to 8.9
AAA, Abdominal aortic aneurysm; CI, confidence interval.
*Rates are per 10,000 person-years in various population groups at risk.
Subjects lost to follow-up were censored from the date of their removal from
the register of the Health Authority.
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We found that in the final year of the study 10 aneu-
rysms expanded to a size that required surgery. This was an
increase from 5 and 6 such expanded AAA in the 2 years
before. Most of these expanded AAA were large aneurysms
that were initially just below the criteria for referral. With
published growth data from the Huntingdon screening
program17 we can predict that in the future approximately
5 small aneurysms per year likely will progress to require
surgery.
In June 1998 we started the second screening round in
the District. To the end of August 2001, 7566 men had
been invited for screening in the second round, and among
these were 2076 new attenders. Five aneurysms eligible for
repair were found in the new subjects, on average fewer
than 2 new aneurysms per year. Therefore, after the first
screening round, the annual number of elective aneurysm
repairs required in the District could be predicted to be
made up of 10 expanded aneurysms in the near future,
decreasing to about 5 per year later on, and finally to 2
“new” aneurysms per year. We estimate that after 5 years
into the second screening round the elective workload as a
result of the screening program would decrease from 12
AAA repairs to about 7 per year. This compares with 8 to 12
elective operations performed annually before screening.
Thus in further screening rounds we would not expect any
more than a minimal number of extra elective repairs com-
pared with the number in the absence of screening, and
there may even be a decrease in elective aneurysm surgery.
Table II. Comparison of hospital and ICU stay and costs between elective and emergency surgery for AAA
Elective AAA repair
(1991-2000)
Emergency AAA repair
(1986-2000)
Number of observations 149 43
Operative mortality (%) 4 51
Median ICU stay in days (range) 2 (1-26) 3 (0-22)
Mean ICU stay in days (95% CI) 2.8 (1.9-3.6) 4.4 (3.3-5.5)
Mean hospital stay in days (CI) 10.4 (8.3-12.7) 14.2 (10.7-17.6)
Mean cost of blood products (95% CI) $256 ($212-$302) $648 ($562-$733)
Median total hospital cost per case (range) $6181 ($3911-$51,901) $9309 ($2180-$46,999)
Mean total hospital cost per case (95% CI) $8061 ($6540-$9583) $11,449 ($9265-$13,631)
AAA, Abdominal aortic aneurysm; ICU, intensive care unit; CI, confidence interval.
Table III. Estimated average costs of emergency repair and elective repair of AAA
Elective AAA repair Emergency AAA repair*
Units Price Cost Units Price Cost
OR costs† 3 $600 $1800 3 $600 $1800
OR consumables‡ $284 $284
Blood products used $256 $648
CT scan 1 $248 $248 0 —
Mean ICU stay 2.8 $1615 $4522 4.4 $1615 $7106
Mean hospital stay 10.5 $144 $1512 14.2 $144 $2044
Total cost per case $8622 $11,882
AAA, Abdominal aortic aneurysm; OR, operating room; CT, computed tomography; ICU, intensive care unit.
*Note that emergency costs relate to all patients in which an operation was attempted, whether or not the patient survived the operation.
†Include OR time and personnel costs.
‡Includes all consumables used in OR.
Table IV. Estimation of costs of screening program
based on costs incurred in 1995
Estimated cost
Salary, ultrasonographer $9,638
Salary, program co-ordinator $7,067
Salary, radiology helper $2,101
Technical support for ultrasound machine $1,264
Telephone costs $790
Patient transport $1,580
Ultrasound examination consumables $790
Total costs of screening program $23,230
Table V. Cost-effectiveness of first round of screening in
Huntingdon Aneurysm Screening program
Cost of screening program per year $23,230
Number of elective AAA repairs per year 10
Cost of elective AAA repair $8,622
Total costs of elective AAA repairs per year $86,220
Number of ruptured AAA prevented per year 10.4
Cost of ruptured AAA repair $11,882
Total savings on emergency AAA repair per year $49,194.79
Total cost per year $60,255.21
Life-years gained per year 51
Cost per life-year gained $1173
AAA, Abdominal aortic aneurysm.
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A predicted cost-effectiveness analysis for a second
round of screening based on these data is shown in Table
VI. If 3 emergency repairs per year per 10,000 persons
could be prevented, the cost of the screening program
would equal predicted savings. Thus, if screening can re-
duce the incidence of ruptured AAA by 64% and the
number of elective AAA repairs in further screening rounds
is no greater than the number in the absence of screening,
cost for the screening program and consequent treatment
can be entirely offset by savings on emergency repairs; ie, it
would be cost-neutral.
We conclude that screening for asymptomatic AAA in
men can be cost-effective in a population with an incidence
of ruptured AAA of more than 7 per 10,000 person-years
and in which a minimum of 5 elective AAA repairs per
10,000 men per year are being performed without screen-
ing. This is the equivalent of the 8 to 10 elective AAA
repairs performed in our District before screening.
Number of AAA needed to treat. In the absence of
screening, we would have expected 52 deaths due to rup-
tured AAA during the study period in the screening arm,
compared with the 17 observed. On this basis, 35 deaths
would have been prevented. In total, 18,059 men were
invited, and 13,466 men were screened during the study
period. Ninety-eight elective AAA repairs were performed
as a result of screening, with 4 perioperative deaths in this
group. Thus, 35 – 4 31 lives are likely to have been saved
in the screening arm. Thirty-one lives saved per 18,059
men invited for screening means that 610 men would have
to be invited for screening to save 1 life. Similarly, 98
elective operations as a result of screening were necessary to
save these 31 lives. On these assumptions, we can estimate
that 3 elective operations are needed to save 1 life.
DISCUSSION
We estimate the cost per life year saved for the first
round of a whole District screening program for asymp-
tomatic AAA in men older than 50 years at $1173. This is
based on accurate evaluation of an actual screening pro-
gram and includes community mortality. This figure
proved similar to the cost per life-year saved predicted by
Law et al.7 In an earlier report of the first 5 years of the
screening program, we had estimated a 49% reduction in
incidence of ruptured AAA.11 After 9 years of screening,
this reduction has risen to 64%, suggesting that the benefits
of screening increase with longer follow-up.
Every effort has been made to come to an accurate
assessment of costs, reflected in the agreement of our
estimates with other recent publications. A report from the
UK Small Aneurysm Trial participants concluded that av-
erage actual cost for elective repair of AAA was $7255.18 A
study from Ireland estimated average cost of IR$6265
($8532) for emergency repair of a ruptured AAA.19
In an examination of which factors had the greatest
influence on cost-effectiveness, we subjected our model of
cost per life-year saved to one-way sensitivity analysis, with
different values for key variables (Table VII). This demon-
strates that the cost-effectiveness of aneurysm screening is
influenced primarily by the effect of screening on reducing
incidence of ruptured aneurysm rather than by variations in
operation cost or mortality from elective surgery. Further-
more, the number of deaths associated with elective surgery
and emergency surgery in our study are comparable to
published figures. We believe therefore that the small num-
bers do not limit the validity of our conclusions.
We believe that our study is unbiased without strict
randomization, because with the stepped wedge design
each subject acted as his own control. Furthermore, there
was no predetermined order in which general practitioners
were asked to participate in screening, and invitation of
subjects within practices was simply in alphabetical order
according to surname. The time when any given subject
entered the invited cohort could not have been predicted.
Volunteer bias was minimized by using “intention to treat”
analysis, based on whether an invitation had been given
rather than on whether screening had taken place. A ran-
domized trial of screening from Chichester demonstrated a
55% reduction in incidence of ruptured AAA in men invited
for screening, compared with the control group.20 An
observational study from Gloucester, with a different
Table VI. Cost-effectiveness of second round of
screening in Huntingdon Aneurysm Screening program
Cost of screening program per year $32,000
Number of extra elective AAA repairs per year 0
Cost of elective AAA repair $9,900
Total costs of extra elective AAA repairs per year $0
Number of ruptured AAA prevented per year 10.4
Cost of emergency repair of ruptured AAA $13,000
Total savings on emergency AAA repair per year $53,820
Total cost per year $21,820
Life-years gained per year 52
Cost per life-year gained $425
Number of expected repairs is based on analysis of expansion data in patients
with small aneurysms followed up in Huntingdon Aneurysm Screening
Program. Increase in costs of 5% per year has been used in these calculations
to account for inflation over 6 years. Figures rounded off to indicate that
these are estimates.
Table VII. Sensitivity analysis
Variable substituted
Cost per
life-year
gained
Upper limit of cost AAA repair ($51,901 and $46,999) $6771
Lower limit of cost AAA repair ($3911 and $2180) $1038
Elective operative mortality of 2% $1142
Elective operative mortality of 8% $1239
Reduction in incidence of ruptured AAA of 42%
(lower limit CI)
$2497
Reduction in incidence of ruptured AAA of 77%
(higher limit CI)
$789
Reduction in incidence of ruptured AAA of 25% $4843
Sensitivity analysis of cost-effectiveness analysis of screening is achieved by
substituting different values for variables in column 1 of Table V. Values of
cost variables are derived from Table II.
AAA, Abdominal aortic aneurysm.
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screening method and a different study design, found a 66%
reduction in incidence of ruptured AAA.21 A recent study
from Denmark, which did not include deaths outside the
hospital, found a 74% reduction in incidence of ruptured
AAA and a 68% reduction in cause-specific mortality.22
These authors estimated a cost of $993 per life-year
saved.22 These estimates are similar to ours and confirm our
findings.
The cost-effectiveness of screening for asymptomatic
AAA compares favorably with other screening programs.
The cost per life-year gained was one third the published
cost per life-year gained with breast cancer screening or
colorectal cancer screening23-27 and one eighth the cost per
life-year saved with cervical cancer screening.28,29 The
number of persons required to be screened for AAA is one
tenth the estimated number required to be screened for
breast cancer to save 1 life.25
CONCLUSION
The cost per life-year gained during the first 10 years of
the Huntingdon Abdominal Aortic Aneurysm screening
program compares favorably with the equivalent costs of
breast and cervical cancer screening. Screening for asymp-
tomatic AAA can be cost-effective in populations in which
incidence of ruptured aneurysm, in the absence of screen-
ing, is more than 5 per 10,000 person-years, and if screen-
ing can reduce this incidence by at least 50%
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